







Our WallFlex Esophageal Stents deliver luminal patency in patients with esophageal strictures caused by intrinsic and/or extrinsic malignant tumors, through combination of flexibility and control for optimized patient care.
Model: Fully Covered Removable
Working Length (cm): 78.0
Length (cm): 10.3
Package Quantity: 1
Stent O.D. (mm): 18.0
Stent Flare Diameter (mm): 23
Catheter Diameter (Fr): 18.5
Catheter Diameter (mm): 6.2
Cover Length (mm)
Stent Length (mm)
Product Code: M00516270
Add to Product List Remove from Product List- WallFlex™ Esophageal Fully Covered RMV 18X103
- GTIN:08714729905523
- Model:Fully Covered Removable
- Working Length (cm):78.0
- Length (cm):10.3
- Package Quantity:1
- Stent O.D. (mm):18.0
- Stent Flare Diameter (mm):23
- Catheter Diameter (Fr):18.5
- Catheter Diameter (mm):6.2
Product Documents
Instructions for Use
Reach out to our technical team for more support.
Technical specifications
Filter results
Model
Length (cm)
Stent O.D. (mm)
Stent Flare Diameter (mm)
Cover Length (mm)
Stent Length (mm)
WallFlex™ Esophageal Fully Covered RMV 18X103
M00516270WallFlex™ Esophageal Fully Covered RMV 18X123
M00516280WallFlex™ Esophageal Fully Covered RMV 18X153
M00516290WallFlex™ Esophageal Fully Covered RMV 23X105
M00516300WallFlex™ Esophageal Fully Covered RMV 23X125
M00516310WallFlex™ Esophageal Fully Covered RMV 23X155
M00516320WallFlex™ Partially Covered Eso Stent 18/23mmx103mm
M00516900WallFlex™ Partially Covered Eso Stent 18/23mmx123mm
M00516910WallFlex™ Partially Covered Eso Stent 18/23mmx153mm
M00516920WallFlex™ Partially Covered Eso Stent 23/28mmx105mm
M00516930WallFlex™ Partially Covered Eso Stent 23/28mmx125mm
M00516940WallFlex™ Partially Covered Eso Stent 23/28mmx155mm
M00516950
Clinical Information
Study results found that placement of a WallFlex Fully Covered Oesophageal Stent resulted in safe and effective palliation of malignant dysphagia
Dr. Allesandro Repici et al. authored the largest study on the WallFlex Fully Covered Esophageal Stent, which was published in the December 2014 issue of Digestive and Liver Disease Journal. The goal of the study was to assess the clinical (recurrent dysphagia) and technical success using the WallFlex Fully Covered Oesophageal Stent in patients with dysphagia due to primary inoperable oesophageal cancer.
The study found that placement of a WallFlex Fully Covered Esophageal Stent resulted in safe and effective palliation of malignant dysphagia. The median dysphagia scores improved from “3” (ability to swallow liquids only) to “1” (ability to eat some solid food) at both fourteen days and four weeks after stent placement. In addition, twenty-four of the eighty-two patients (29.2%) went on to receive chemo and/or radiotherapy after stent placement.
The article, Management of Inoperable Malignant Oesophageal Strictures with Fully Covered WallFlex Stent: A multicentre Prospective Study is available at https://www.ncbi.nlm.nih.gov/pubmed/25262010.
DISCLAIMER: All trademarks are the property of their respective owners.
ENDO-1137011-AA